Off the wire
• Weather forecast for major Chinese cities, regions -- May 9  • Maintaining healthy, stable development of Sino-US trade ties in global interest: FM spokesperson  • DPP administration bears full responsibility for Taiwan not being invited to WHA: FM spokesperson  • Legendary Chinese art connoisseur celebrated in Beijing  • Carlos Alvarado sworn in as president of Costa Rica  • Namibia continues with energy saving campaign to eliminate inefficient bulbs  • Ireland sales of new vehicles down, but used ones up in 1st 4 months  • Train collision leaves two dead in Germany  • Weather forecast for major Chinese cities, regions -- May 9  • Maintaining healthy, stable development of Sino-US trade ties in global interest: FM spokesperson  
You are here: 　

Tanzania starts trials for HIV preventive treatment

Xinhua,May 10, 2018 Adjust font size:

DAR ES SALAAM, May 9 (Xinhua) -- The government of Tanzania has started trials of pills that can prevent one from contracting HIV, a senior official said on Wednesday.

Faustine Ndugulile, the deputy minister of health, however, said "What we have launched is a preventive medicine, and this is meant for groups of people who are at high risk of contracting HIV. The pills will help such people not to contract HIV. We are also making trials and the drug is not yet available on the market."

He said the preventive treatment, known medically as Pre-exposure prophylaxis (PrEP), has been launched as part of Tanzania's fourth Health Sector HIV/AIDS Strategic Plan 2017-2022.

The pills are known to prevent HIV infection by 99 percent. They have already been rolled out in some sub-Saharan countries such as South Africa and Kenya.

Ndugulile said the trails were part of Tanzania's long-term measures to curb HIV/AIDS, adding: "It has also come at a time the country is marking 30 years of the HIV/AIDS Prevention Plan."

According to statistics by the Tanzania Commission for AIDS (TACAIDS), Tanzania has an estimated 1.4 million people living with HIV/AIDS but only 52 percent of them are aware of their condition.

The disease has mostly affected the youth aged between 14 and 25 years, says TACAIDS. Enditem

 

Related News & Photos